Xiaolin is a medical doctor, public health specialists, professor and the Dalla Lana Chair in Global Health Policy in the University of Toronto, Canada. He was elected as a Fellow of the Canadian Academy of Health Sciences. Prof. Wei is an internationally recognized leader at using implementation science frameworks in health service research, specifically in the control of tuberculosis, diabetes/hypertension, antimicrobial resistance (AMR) and recently in COVID-19. His scholarship has reformed health policies to promote quality and equitable care in COVID-19, tuberculosis, AMR and diabetes at national and global levels. He has served as the Vice President and Secretary General of the International Union Against Tuberculosis and Lung Disease in driving global TB policy change.
He currently leads a project in Ontario examining the population protection effect of hybrid immunity (previous infection + vaccines) on COVID hospitalization and death using the Ontario Health Data Platform (OHDP). He also leads two implementation science studies, one is to improve vaccine confidence among the poor in the Philippines, and another is to improve non-communicable disease management in rural Pakistan using telemedicine.